… can be used as reliever medications for in-between symptoms … one. I often develop a cold and cough and sometimes wheeze, … medicines in micrograms and these drugs stay in lung and … with spirometry and with regular treatment with inhaled corticosteroids, one …

… tested positive for whooping cough after visiting the Kidspace … . Infants may not develop a cough but could turn red … anyone in their household develops a persistent cough or cold symptoms. … days of appropriate antibiotic treatment. Babies and pregnant women …

… several treatments in oncology were approved by the FDA. The … AK105-202 (NCT03866967) trial. The trial assessed 125 patients … Ireland pharmaceutical company that developed the product.6 This … .fda.gov/drugs/resources-information-approved-drugs/fda …

… fever, runny nose and cough. The cough often then progresses to a … and erythromycin. The earlier the treatment begins, the better the prognosis … declining. This is an unfortunate development. People should be reminded that …

… of foods, drinks, and even medications. From sweet treats to cold … for decades.  But now, the FDA says it's time … , 2027, and from ingestible drugs like cough syrup by January 18, 2028 … juice or beet juice," FDA Commissioner Marty Makary said. …

… approved only nine novel drugs - new molecular entities … symptoms such as breathlessness, cough, and sputum, along with … therapy is being developed for the treatment of both pulmonary arterial … FDA, with a decision due on May 31, 2025. In clinical trials …

… , once-a-day pill called brenso­catib as a … trial findings are important, as there are currently no FDA-approved medications … Symptoms of bronchiectasis include chronic cough with sputum (mucous) … the first-ever FDA-approved treatment for bronchiectasis." …

… Journal of Medicine. The trial evaluated mepolizumab, a monoclonal … the EU. The US FDA has provided a PDUFA date … symptoms such as breathlessness, cough, and sputum along with … to deliver more ambitious treatment goals, develop the next generation standard …

… fever, muscle weakness, cough, breathing difficulties, and … aims to accelerate vaccine development against epidemic threats. … treatments for Nipah, but one—ChAdOx1 NipahB—entered its first human trial … last year. This vaccine, developed by …

… 9,000 bottles of codeine cough syrup were taken for destruction … Excise, Dimapur, for pre-trial destruction of the seized articles … for pre-trial destruction of the seized narcotics and other drugs,” she … 9,000 bottles of codeine cough syrup. The seized items …